Home » Topics » BioWorld Science

BioWorld Science
RSS

Lower affinity means lower affinity, but higher persistence, for CAR T cells

Sep. 3, 2019

Alcohol consumption is deceased with FGFR1 inhibition in rodents

Sep. 3, 2019

First preclinical data presented on miR-132 inhibitor CDR132L in heart failure model

Sep. 3, 2019

Panitumumab-IRDye800 in phase II for metastatic lymph node identification in HNSCC

Sep. 3, 2019

POU3F3 disruptions linked to neurodevelopmental disorder

Sep. 3, 2019

Checkpoint blockade protects from homeostatic inhibition and amplifies antitumor T-cell responses

Sep. 3, 2019

Preclinical characterization of the novel covalent Inhibitor of CDK7, SY-1365

Sep. 3, 2019

Phase II data reported for P2Y12 inhibitor selatogrel in CAD patients

Sep. 2, 2019

TLR4 agonist INI-2004 as immunostimulant for the treatment of infectious diseases

Sep. 2, 2019

A reverse engineering approach for in vitro modeling of the human eye

Sep. 2, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...